Phase II study of RAD001 in a neoadjuvant setting in men with intermediate or high risk prostate cancer
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 19 Jan 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 May 2008 New trial record.